Steroid 17-hydroxyprogesterone in hair is a potential long-term biomarker of androgen control in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Introduction To evaluate scalp hair steroid concentrations as a monitoring tool for androgen control in adults with congenital adrenal hyperplasia due to 21-hydroxylase deficiency (CAH). Methods Scalp hair 17-hydroxyprogesterone (17-OHP), androstenedione, testosterone, cortisol, cortisone, progesterone, prednisolone and prednisone concentrations were measured by means of LC-MS/MS in women (N=27) and men (N=15) with CAH and controls (37 women, 42 men). Results In CAH men and women, 17-OHP levels in hair showed a significant positive correlation with corresponding levels in serum (ρ = 0.654; p = 0.01; ρ = 0.553, p = 0.003 respectively), while total testosterone levels were only significantly correlated in CAH men (ρ = 0.543; p = 0.036). Androstenedione levels did not correlate significantly. Receiver operating characteristic (ROC) analysis indicated that a cut-off value of 21.7pg/mg for 17-OHP in hair provided a sensitivity of 100% and a specificity of 88.9% for identifying men with elevated serum androstenedione. Hair 17-OHP in women showed a poorer performance in terms of identifying those with elevated androstenedione serum levels. However, when applying a cut-off value of 5.5 for the free androgen index (FAI) as a marker of significant hyperandrogenism in CAH women, 17-OHP >27.6pg/mg in hair provided a sensitivity of 100% and a specificity of 95.8% (AUC 0.986, 95CI% 0.945-1.000; p <0.001). Conclusion This study shows that scalp hair 17-hydroxyprogesterone concentrations may be a promising non-invasive long-term parameter for treatment monitoring in adult patients with CAH.